Subject-matter experts from different disciplines gathered to provide relevant insights into stem cell and developmental biology, organ system function, and innovative approaches to regenerate or bioengineer a kidney.
Discover the beneficial effect of pulsed magnetic fields to help improve you health and well being. PEMF are natural and non medicated and contribute to reduce pain and swelling
michel.gareau@centurionsystems.com
www.pemfcenturion.com
Marom Bikson speaks at the BrainSTIM2015 - Targeting transcranial Electrical Stimulation (tES) using EEG. Includes how to use EEG to inform transcranial Direct Current Stimulation (tDCS) montages. And critical pitfalls in concurrent recording. Stay tuned for our upcoming paper on reciprocity.
The complete video can be found here: https://www.youtube.com/watch?v=yYmDQB7qSCE
The first publication on the topic can be found here http://neuralengr.com/wp-content/uploads/2016/05/2016-Cancelli-A-simple-method.pdf
Related technology can be found here http://soterixmedical.com/research/monitoring/eeg
A selection of works I did in past 15 years through industrial design, graphic design and strategic marketing.
Una selezione dei lavori fatti negli ultimi 15 anni, attraverso la comunicazione grafica, il design di prodotto e il marketing strategico.
Leaders in the fields of lung function and mechanics, lung progenitor cell biology, and lung engineering gathered in La Jolla in January 2015 to share observations and strategies for advancing the field of lung regeneration and to to launch a transdisciplinary, science-driven effort to engineer a human lung.
Discover the beneficial effect of pulsed magnetic fields to help improve you health and well being. PEMF are natural and non medicated and contribute to reduce pain and swelling
michel.gareau@centurionsystems.com
www.pemfcenturion.com
Marom Bikson speaks at the BrainSTIM2015 - Targeting transcranial Electrical Stimulation (tES) using EEG. Includes how to use EEG to inform transcranial Direct Current Stimulation (tDCS) montages. And critical pitfalls in concurrent recording. Stay tuned for our upcoming paper on reciprocity.
The complete video can be found here: https://www.youtube.com/watch?v=yYmDQB7qSCE
The first publication on the topic can be found here http://neuralengr.com/wp-content/uploads/2016/05/2016-Cancelli-A-simple-method.pdf
Related technology can be found here http://soterixmedical.com/research/monitoring/eeg
A selection of works I did in past 15 years through industrial design, graphic design and strategic marketing.
Una selezione dei lavori fatti negli ultimi 15 anni, attraverso la comunicazione grafica, il design di prodotto e il marketing strategico.
Leaders in the fields of lung function and mechanics, lung progenitor cell biology, and lung engineering gathered in La Jolla in January 2015 to share observations and strategies for advancing the field of lung regeneration and to to launch a transdisciplinary, science-driven effort to engineer a human lung.
The slide presentation from PCORI'S Advisory Panel on Assessment of Prevention, Diagnosis, and Treatment Options April 28-29, 2014 meeting in Alexandria, VA.
Kim Solez Introduction to regenerative medicine Fall 2015Kim Solez ,
Dr. Kim Solez presents "Introduction to Regenerative Medicine" on September 10, 2015 in the Technology and Future of Medicine course LABMP 590 http://www.singularitycourse.com at the University of Alberta in Edmonton, Canada. Copyright (c) 2015, JustMachines Inc.
1st International Conference Models of Human Diseases oral presentations abstracts feature recent findings in development or emplyment of various models of diseases to advance biomedical research.
Kim Solez Transition transplant path to tissue engineering path new banffKim Solez ,
Dr. Kim Solez Presents "Transition Between Transplant Pathology and Tissue Engineering Pathology: Beginning A New Banff Classification" at the Alberta Transplant Institute Fellows Lecture Series January 10, 2017 at the University of Alberta in Edmonton, Alberta, Canada. Copyright (c) 2017, JustMachines Inc.
Professionals and families from across Europe will be attending the Alstrom Syndrome UK Scientific Symposium on the 6th October 2017 in Birmingham, UK. Bringing together researchers, clinicians, professionals and families to discuss rare disease research, clinical developments and an opportunity to network with like-minded professionals. The agenda for this unique event is now available and further information can be found via the ASUK website http://www.alstrom.org.uk/ASUK-conference/
Klose lymphedema conference 2011 faculty and programklosetraining
We are honored to present Prof. Ethel Földi, MD as our Keynote Speaker. Prof. Földi is an internationally recognized authority on clinical lymphedema and lymphatic disorders. She serves as the Medical Director at the world-renowned Földi Clinic, specializing in the diagnosis and treatment of patients with lymphedema. Currently, Prof. Földi is the president of the Society of German-speaking lymphologists and a member of the International Advisory Committee to the National Lymphedema Network (NLN). She is also a past-President of the International Society of Lymphology (ISL).
Kim Solez TEP meets Human Cell Atlas a glimpse into future of pathology winte...Kim Solez ,
Dr. Kim Solez TEP meets Human Cell Atlas Project, a glimpse into future of pathology, Technology and Future of Medicine course February 15, 2018 http://www.singularitycourse.com Copyright (c) 2018, JustMachines Inc.
GLOBAL SUMMIT ON HEALTH-TECHNOLOGY- EDUCATION:
FINDING AFFORDABLE SOLUTIONS FOR URGENT SOCIAL & HUMAN PROBLEMS

Affordable innovation can help transform the health, education, and quality of life of the billions of people across the planet. This is essential for the peace and prosperity of mankind. The intersections of today’s life and location-independent digital technologies offer us a unique opportunity to leverage global knowledge to find solutions much quicker and cheaper than we could ever imagine.
Cambridge Healthtech Institute (CHI) is pleased to announce the Third Annual FAST: Functional Analysis and Screening Technologies Congress. Now in its third year, the FAST Congress brings you the latest technologies and research in cellular screening.
The Third Annual Phenotypic Drug Discovery meeting will return with new updates and case studies in phenotypic screening, high-content analysis, physiologically-relevant cellular models, chemical genomics and chemical proteomics. The rapidly evolving area of 3D cellular models will be addressed by two back-to-back meetings, with the Inaugural 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models meeting focusing on the new predictive cellular models for drug discovery and toxicity assessment. It will review the use of primary and stem cells, complex co-culture cell models, tumor spheroid models, novel organ-on-a-chip models for efficacy and safety screening, functional analysis, and compound profiling. The Third Annual Screening and Functional Analysis of 3D Models meeting will follow with case studies of phenotypic and high-content screening of complex 3D cellular systems for compound and target selection.
The 2014 Congress attracted more than 250 senior delegates, representing over 160 companies from 20 countries. With half of the attendees from big pharma and biotech and a third from academia and government, the FAST Congress offers exclusive networking opportunities with diverse international attendance. Please join our focused Screening event and learn from 60+ scientific presentations, an assortment of educational courses, 20+ exhibitors and your fellow expert delegates. We look forward to seeing you at the event.
Kim Solez Bridge between transplantation and regenerative medicine vancouver3Kim Solez ,
Dr. Kim Solez presents "Bridge between Transplantation and Regenerative Medicine" at the Banff Transplant Pathology meeting in Vancouver October 5, 2015. Copyright (c) 2015, JustMachines Inc.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
2. 6:15 p.m.
Structural Basis of Essential Kidney Functions
Dennis Brown, Harvard University
6:30 p.m.
Experience with Renal Assist Devices
Christopher J. Pino, University of Michigan
6:45 p.m.
Current State of Transplantation
John P. Vella, Maine Medical Center
7:00 p.m.
Q&A + Group Discussion
Led by SOS Chief Science Coordinators
Realistic Expectations:
What Clinicians Need
Right Now
Module 1
Tonight’s clinical perspective is
designed to lay the foundation for
tomorrow’s discussion.
3. Thomas Carroll, PhD
Department of Nephrology,
UT Southwestern Medical Center
Leif Oxburgh, DVM, PhD
Center for Molecular Medicine,
Maine Medical Centre Research Institute
How to think about
Phase One Strategic
Research Goals
Module 1
KIDNEY COORDINATORS
5. Laying the Foundation
Thank you for participating in the
first SOS Kidney Summit, a gathering
specifically focused on what it’s
going to take to regenerate or
bioengineer a kidney for human
transplantation.
Identify challenges we need to overcome to
advance the science.
Prepare a meeting report for stakeholders.
Form a working group focused on Phase One
Strategic Research Goals.
03
01
02
6. Rapid-Learning Modules
The Summit is organized into four
Rapid-Learning Modules covering
key topics. Each module is comprised
of 15-minute presentations from
subject-matter experts and concludes
with a Q&A session.
MODULE 1
Realistic Expectations: What Clinicians
Need Right Now
MODULE 2
Repair: Is It Possible to Build Kidney Tissue
In Situ?
MODULE 3
Building Blocks: Cell Sources for Tissue
Generation
MODULE 4
Biological Structure: Issues to Consider in
Engineering De Novo Kidney Tissue
7. Repair: Is It Possible to Build Kidney Tissue In Situ?
Module 2
9:30 a.m.
Cellular Approaches Used to Enhance
Regeneration in Injured Kidneys
Lloyd G. Cantley, MD
9:15 a.m.
Lessons Learned From Zebrafish About
Regenerating Kidney Tissue
Iain A. Drummond, PhD
Q&A / Group Discussion
9:45 a.m.
9:00 - 10:30 a.m. | 1HR 30M
9:00 a.m.
How Cell Developmental Processes Can Be
Reactivated to Repair Damaged Organs
Manuel Serrano, PhD
8. Module 3
Building Blocks: Cell Sources for Tissue Generation
10:30 a.m. - Noon | 1HR 30M
Q&A / Group Discussion
11:15 a.m.
10:30 a.m.
Status of Reproducibility, Genetic State and
Immune Tolerance of iPSCs and hESCs
Samantha Morris, PhD
10:45 a.m.
Generating Cell Types Needed for De Novo
Nephrogenesis
Andrew McMahon, PhD
11:00 a.m.
Scientific and Ethical Challenges of
Xenotransplantation
David K.C. Cooper, MD, PhD, FRCS
9. Please enjoy lunch and plan to be back in your seat
by 12:55 p.m. We will resume promptly at 1 p.m.
LUNCH Noon - 1 p.m. | 1HR
10. Module 4 1:00 - 3:45 p.m. | 2HR 45M
Biological Structure: Issues to Consider in Engineering De Novo
Kidney Tissue
1:00 p.m.
Essential Angiogenesis Parameters for De
Novo Tissue Generation
Ondine Cleaver, PhD
1:15 p.m.
Key Glomerulus Features to be Included in
Engineered Kidney Tissue
Stuart Shankland, MD
1:30 p.m.
Pros and Cons of Using a Decellularized ECM
to Engineer a De Novo Kidney
Jason A. Wertheim, MD, PhD
1:45 p.m.
Pros and Cons of Using Artificial Scaffolds to
Engineer De Novo Kidney Tissue
David Kaplan, PhD
2:00 p.m.
Group Discussion
2:45 p.m.
Phase One Strategic Research Goals
12. Form the Whole Kidney Research Community Please complete the
form in your registration packet and give it to an SOS staff member.
Disseminate Meeting Report This report will define our starting line
and will be shared with a variety of stakeholders.
Secure Funding for Research Initiatives Our mission is to raise
money to fund high impact research initiatives.
01
02
03
NEXT STEPS
13. Thanks to Dr. Carroll and Dr. Oxburgh for their help in
organizing and leading today’s Summit. And thank you for
your participation!
Thomas Carroll
Chief Science Coordinator, Kidney
UT Southwestern University
Leif Oxburgh
Chief Science Coordinator, Kidney
Maine Medical Center Research Institute
Editor's Notes
We’re going to get started, Leif, can you please introduce the speakers in our first module.